Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
It was January 2023. Elon Musk owned Twitter, but it wasn’t yet called X. ChatGPT had been released barely six weeks earlier. Absci CEO Sean McClain — tall, with short, gelled hair and a beard, the ...
Research from 2025 finds that 77% of executives believe unlocking the true benefits of AI will only be possible when it is built on a foundation of trust, according to the Accenture Technology Vision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results